Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Genmab
University of Pittsburgh
University of Ulm
University of Pittsburgh
University of California, San Diego
Merck Sharp & Dohme LLC
University of California, San Diego
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Yale University
Instituto Nacional de Cancer, Brazil
University College, London
ARCAGY/ GINECO GROUP
University College, London
Imperial College London
University Health Network, Toronto
Sunnybrook Health Sciences Centre
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
The Netherlands Cancer Institute